The closest alternative to Zepbound is Wegovy (semaglutide), another injectable GLP-1 that produces 15% average body weight loss. If injections aren't right for you, phentermine and Contrave are oral options that work through different mechanisms. Your clinician can recommend the best fit based on why Zepbound isn't working for you.
Why you might need an alternative to Zepbound
Zepbound (tirzepatide) is one of the most effective weight loss medications available, but it's not the right fit for everyone. Common reasons patients explore alternatives include:
- Insurance denial — your plan doesn't cover Zepbound, or prior authorization was denied
- Cost — without insurance, Zepbound can be expensive
- Side effects — GI side effects like nausea or diarrhea may be difficult to tolerate
- Step therapy requirements — your insurer requires trying a less expensive medication first
- Contraindications — personal or family history of medullary thyroid carcinoma or MEN 2 syndrome
- Preference for oral medication — some patients strongly prefer pills over weekly injections
Whatever the reason, having options matters. PEAK prescribes multiple FDA-approved weight loss medications and works with each patient to find the right approach.
FDA-approved alternatives to Zepbound
Wegovy is the closest alternative to Zepbound. Both are injectable GLP-1-based medications FDA-approved for chronic weight management. While Zepbound is a dual GIP/GLP-1 receptor agonist acting on both GLP-1 and GIP receptors, Wegovy targets GLP-1 only. Clinical trials show slightly less average weight loss than Zepbound, but many patients respond equally well to either medication.
Best for: patients who want a comparable injectable option, especially if Wegovy has better insurance coverage than Zepbound under their plan.
Learn about Wegovy at PEAK →Saxenda is the first-generation GLP-1 approved for weight loss (2014), using liraglutide at the 3.0 mg dose. It works through the same GLP-1 pathway as Zepbound but targets only the GLP-1 receptor. Daily dosing and a shorter half-life mean side effects tend to resolve more quickly than with weekly injectables.
Best for: patients whose insurance covers liraglutide but not tirzepatide or semaglutide, or those who prefer a daily GLP-1 injection with quicker side-effect resolution.
Learn about Saxenda at PEAK →Phentermine is the most widely prescribed weight loss medication in the United States. It's a sympathomimetic amine that suppresses appetite through the central nervous system. As a generic medication, it's dramatically more affordable than Zepbound and covered by most insurance plans.
Best for: patients who need an affordable starting point, prefer oral medication, or are completing step therapy requirements before GLP-1 approval.
Learn about phentermine at PEAK →Contrave combines naltrexone (which blocks the brain's opioid reward pathway for food) with bupropion (an antidepressant that reduces appetite and increases energy). It works through entirely different mechanisms than Zepbound, targeting the emotional and reward-driven aspects of eating rather than the GLP-1 pathway.
Best for: patients with emotional or reward-driven eating patterns, food cravings, or those who prefer an oral medication that addresses the psychological component of appetite.
Learn about Contrave at PEAK →Zepbound vs. alternatives at a glance
| Zepbound | Wegovy | Phentermine | Contrave | |
|---|---|---|---|---|
| Type | GLP-1/GIP dual agonist | GLP-1 agonist | Sympathomimetic amine | Naltrexone + bupropion |
| Administration | Weekly injection | Weekly injection | Daily tablet | Twice-daily tablet |
| Avg. weight loss | 18–22% | ~15% | 5–10% | ~5–6% |
| Monthly cost | Insurance or self-pay | Insurance or self-pay | Varies by plan/pharmacy | Often low cost |
| Insurance coverage | Growing | Most major plans | Most plans | Many plans |
| Duration | Ongoing | Ongoing | Up to 12 weeks | Ongoing |
| Primary side effects | Nausea, diarrhea | Nausea, constipation | Dry mouth, insomnia | Nausea, headache |
| Best for | Maximum weight loss | Strong GLP-1 alternative | Affordable first step | Emotional eaters |
Costs reflect typical ranges with and without insurance. Your actual cost depends on your specific plan. PEAK verifies coverage before prescribing.
What if your insurance denied Zepbound?
Insurance denial is the most common reason patients come to PEAK looking for Zepbound alternatives. If your prior authorization was denied, you have several options:
Appeal the denial
PEAK's team handles prior authorization appeals. Many initial denials are overturned with additional clinical documentation, such as lab work confirming BMI, comorbidity records, or documentation of failed prior treatments. Your clinician can provide a detailed letter of medical necessity.
Complete step therapy requirements
Many insurers require trying a less expensive medication (usually phentermine) before approving a GLP-1 like Zepbound. This typically means a 3-month trial. PEAK manages the entire step therapy process, documenting your response so that when you reapply for Zepbound, the clinical justification is already in place.
Check if Wegovy is covered instead
Some insurance plans cover Wegovy but not Zepbound (or vice versa). Because both are injectable GLP-1 medications with strong clinical evidence, switching to the covered option is often the fastest path to treatment.
Use the manufacturer savings program
Eli Lilly offers savings cards that can reduce the cost of Zepbound for commercially insured patients. PEAK can help you determine if you qualify and walk you through the enrollment process.
Before your first visit, PEAK verifies your insurance coverage and identifies which medications your plan covers. If Zepbound isn't covered, your clinician discusses alternatives during your consultation so you leave with a clear treatment plan — not just a denied claim.
How PEAK helps you find the right alternative
Finding the right weight loss medication isn't just about picking the next option on the list. At PEAK, your clinician considers:
- Why Zepbound isn't working for you — insurance, side effects, and contraindications each point toward different alternatives
- Your weight loss goals — a patient who needs to lose 100+ pounds has different needs than someone targeting 30 pounds
- Your medical history — conditions like uncontrolled hypertension, seizure disorders, or eating disorders affect which medications are safe
- Your preferences — injection vs. oral, once-weekly vs. daily, and cost tolerance all matter
- Insurance coverage — PEAK verifies your specific plan's formulary before recommending a medication
Many patients end up on a medication they didn't originally plan for — and are glad they made the switch. The best medication is the one that works for your body, your budget, and your life.
Unlike telehealth platforms that only prescribe GLP-1s, PEAK offers phentermine, Contrave, Wegovy, and Zepbound. If one medication isn't working or isn't accessible, your clinician can adjust your treatment plan without referring you elsewhere.
A note about compounded tirzepatide
You may have seen compounded tirzepatide offered online at lower prices. PEAK does not prescribe compounded GLP-1 medications. Compounded versions are not FDA-approved, are not manufactured under the same quality standards, and may contain inconsistent dosing. The FDA has issued safety warnings about compounded semaglutide and tirzepatide products.
All medications prescribed at PEAK are FDA-approved, brand-name products dispensed through licensed pharmacies.
Frequently asked questions
-
Wegovy (semaglutide) is the closest alternative. Both are injectable GLP-1 medications FDA-approved for weight loss. Wegovy targets the GLP-1 receptor, while Zepbound targets both GLP-1 and GIP. Clinical results are comparable, though Zepbound tends to produce slightly more weight loss in trials. Many patients respond well to either medication.
-
Yes. Your PEAK clinician can transition you to Wegovy, phentermine, or Contrave depending on why Zepbound isn't the right fit. If it's a cost or insurance issue, Wegovy may be covered. If you prefer an oral option, phentermine or Contrave are available. Your provider creates a transition plan that minimizes disruption to your progress.
-
Not yet. Eli Lilly is developing an oral tirzepatide formulation, but it's not currently available. In the meantime, oral weight loss medications at PEAK include phentermine (a daily appetite suppressant) and Contrave (a twice-daily combination of naltrexone and bupropion). Both are FDA-approved for weight management.
-
PEAK helps with prior authorization appeals, checks if Wegovy is covered under your plan instead, and can start step therapy with phentermine or Contrave to satisfy insurer requirements. Many patients who are initially denied Zepbound eventually gain coverage after completing a documented trial of another medication.
-
PEAK does not prescribe compounded GLP-1 medications. Compounded versions are not FDA-approved, may have inconsistent dosing, and are not manufactured to the same quality standards. The FDA has issued warnings about these products. PEAK only prescribes brand-name medications from licensed pharmacies.